Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma — Johann von Felden (2020) | RDL Network
Johann von Felden, Amanda J. Craig, Ismaïl Labgaa, Teresa García‐Lezana, Delia D’Avola, Amon Asgharpour, Douglas T. Dieterich, Antoinette Bonaccorso, Miguel Torres‐Martín, Daniela Sia, Max W. Sung, Parissa Tabrizian, Myron Schwartz, Josep M. Llovet, Augusto Villanueva
Victoria Tovar, Helena Cornellà, A. Moeni, Samuel J. Vidal, Yujin Hoshida, Daniela Sia, Judit Peix, Clara Alsinet, I.M. Quetglas, Manel Solé, Josep Domingo-Domènech, Augusto Villanueva, Josep M. Llovet
Daniela Sia, Andrew Harrington, Sara Torrecilla, Z. Zhang, Genís Campreciós, Agrin Moeini, S. Toffanin, Isabel Fiel, Ke Hao, Mónica Higuera, Laia Cabellos, Helena Cornellà, Milind Mahajan, Yujin Hoshida, A. Villanueva, Sander Florman, Marc Schwartz, Josep M. Llovet
Ismaïl Labgaa, Carlos Villacorta-Martín, Delia D’Avola, Amanda J. Craig, Johann von Felden, Sebastiao N. Martins‐Filho, Daniela Sia, Ashley Stueck, Stephen C. Ward, Maria Isabel Fiel, Milind Mahajan, Parissa Tabrizian, Swan N. Thung, Celina Ang, Scott L. Friedman, Josep M. Llovet, Myron Schwartz, Augusto Villanueva
Discussion(0)
No comments yet. Be the first to comment.